Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sodium chloride 0.9% veterinary
- Development stage
- Unknown
- Lead developer
- Halex Istar
- Modality
- Small Molecules
- Administration
- Intravenous, Parenteral
01
Overview
Sodium Chloride 0.9% Veterinary is an approved sterile, isotonic, and nonpyrogenic parenteral solution developed by the Brazilian pharmaceutical company Halex Istar. Also known as normal saline, it contains sodium chloride (NaCl) at a concentration of 0.9% w/v. The solution is primarily administered via intravenous infusion to restore fluid and electrolyte balance in veterinary patients. It is indicated for the treatment of dehydration, electrolyte depletion, and fluid imbalances in various animal species, and it also serves as a compatible vehicle or diluent for the administration of other injectable veterinary medications.
- Other names
- Cloreto de Sódio 0,9% VeterinárioVeterinary Sodium Chloride 0.9%normal saline
Beyond the preview
Go deeper on sodium chloride 0.9% veterinary.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sodium chloride 0.9% veterinary.